These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 17409427)
1. Cellular transformation and activation of the phosphoinositide-3-kinase-Akt cascade by the ETV6-NTRK3 chimeric tyrosine kinase requires c-Src. Jin W; Yun C; Hobbie A; Martin MJ; Sorensen PH; Kim SJ Cancer Res; 2007 Apr; 67(7):3192-200. PubMed ID: 17409427 [TBL] [Abstract][Full Text] [Related]
2. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416 [TBL] [Abstract][Full Text] [Related]
3. c-Src is required for tropomyosin receptor kinase C (TrkC)-induced activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. Jin W; Yun C; Jeong J; Park Y; Lee HD; Kim SJ J Biol Chem; 2008 Jan; 283(3):1391-1400. PubMed ID: 17991742 [TBL] [Abstract][Full Text] [Related]
4. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799 [TBL] [Abstract][Full Text] [Related]
5. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Lannon CL; Sorensen PH Semin Cancer Biol; 2005 Jun; 15(3):215-23. PubMed ID: 15826836 [TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996 [TBL] [Abstract][Full Text] [Related]
8. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation. Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity. Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160 [TBL] [Abstract][Full Text] [Related]
10. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754 [TBL] [Abstract][Full Text] [Related]
11. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation. Hosoya N; Qiao Y; Hangaishi A; Wang L; Nannya Y; Sanada M; Kurokawa M; Chiba S; Hirai H; Ogawa S Genes Chromosomes Cancer; 2005 Mar; 42(3):269-79. PubMed ID: 15611931 [TBL] [Abstract][Full Text] [Related]
12. c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells. Choudhury GG; Mahimainathan L; Das F; Venkatesan B; Ghosh-Choudhury N Cell Signal; 2006 Nov; 18(11):1854-64. PubMed ID: 16530387 [TBL] [Abstract][Full Text] [Related]
13. nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1. Tejedo JR; Cahuana GM; Ramírez R; Esbert M; Jiménez J; Sobrino F; Bedoya FJ Endocrinology; 2004 May; 145(5):2319-27. PubMed ID: 14764634 [TBL] [Abstract][Full Text] [Related]
14. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Akagi T; Murata K; Shishido T; Hanafusa H Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282 [TBL] [Abstract][Full Text] [Related]
15. A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation. Tognon CE; Martin MJ; Moradian A; Trigo G; Rotblat B; Cheng SW; Pollard M; Uy E; Chow C; Carboni JM; Gottardis MM; Pollak M; Morin GB; Sorensen PH Oncogene; 2012 Mar; 31(10):1334-40. PubMed ID: 21804605 [TBL] [Abstract][Full Text] [Related]
16. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation. Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677 [TBL] [Abstract][Full Text] [Related]
17. Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells. Lei J; Ingbar DH Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L765-71. PubMed ID: 21840963 [TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Basile JR; Afkhami T; Gutkind JS Mol Cell Biol; 2005 Aug; 25(16):6889-98. PubMed ID: 16055703 [TBL] [Abstract][Full Text] [Related]
19. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study. Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738 [TBL] [Abstract][Full Text] [Related]
20. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]